Wasim Iyad Ibrahim Alghoul, Ibrahim Alabid, Malak Moones Abedi, Mohamedanas Mohamedfaruk Patni, Biji Thomas George, Subhranshu Sekhar Kar, Rajani Dube, Wed Burhan Jameel Al-Shammari, Mohamed Osman Elhag Osman, Riza Jazlin Neyyappadath, Subhanka Nagabhatla, Aya Sabir Salah Ahmed
{"title":"Before Sepsis Strikes: Artificial Intelligence for Early Prediction of Postoperative Sepsis and Sepsis-Related Complications After Major Abdominal Surgery-A Systematic Review.","authors":"Wasim Iyad Ibrahim Alghoul, Ibrahim Alabid, Malak Moones Abedi, Mohamedanas Mohamedfaruk Patni, Biji Thomas George, Subhranshu Sekhar Kar, Rajani Dube, Wed Burhan Jameel Al-Shammari, Mohamed Osman Elhag Osman, Riza Jazlin Neyyappadath, Subhanka Nagabhatla, Aya Sabir Salah Ahmed","doi":"10.3390/medsci14060685","DOIUrl":"10.3390/medsci14060685","url":null,"abstract":"<p><strong>Background: </strong>Postoperative sepsis and related infectious complications remain major causes of morbidity after abdominal surgery. Artificial intelligence (AI) and machine learning (ML) models may support earlier risk stratification, but their generalizability and clinical readiness remain uncertain.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, and CENTRAL from inception to 10 August 2026 for studies developing, validating, or evaluating AI/ML models for postoperative sepsis, postoperative infection/surgical-site infection (SSI), anastomotic leakage, or postoperative pancreatic fistula (POPF) after major abdominal or general surgery. SSI, anastomotic leakage, and POPF were analyzed as distinct postoperative endpoints and were not treated as proxy definitions of clinical sepsis. Study selection and data extraction were performed independently by two reviewers, and risk of bias and applicability were assessed using PROBAST + AI. Owing to substantial clinical and methodological heterogeneity, results were synthesized narratively. The review was registered in PROSPERO (CRD420261492111).</p><p><strong>Results: </strong>Forty-five studies were included: 11 addressed sepsis-related outcomes, including six studies with a primary sepsis-related modeled endpoint whose definitions ranged from consensus Sepsis-3 criteria to coded or SIRS-based definitions and a qSOFA-based proxy; 19 evaluated postoperative infection/SSI; eight anastomotic leakage; five POPF; and two broader postoperative complications. Performance varied according to outcome, surgical population, prediction timing, predictor availability, and validation strategy. Fifteen of 45 studies provided strict temporal, geographic/external-center, or independent-investigator evaluation of the principal model, with variable preservation of performance outside development settings. More complex ML methods did not reliably outperform conventional regression. Explicit calibration analysis was reported in 9/45 studies, decision-curve or net-benefit analysis in 7/45, and no study prospectively evaluated the impact of model-guided care on clinical outcomes. Certainty of evidence was very low for primary postoperative sepsis/septic-shock prediction, low for postoperative infection/SSI, and very low for anastomotic leakage and POPF.</p><p><strong>Conclusions: </strong>Although several AI/ML models showed promising predictive performance, the available evidence remains insufficient to support routine use of AI/ML prediction models across major abdominal surgical populations. Future studies should prioritize clearly defined clinical use cases, multicenter external validation, calibration, prospective workflow evaluation, and demonstration of actionable clinical benefit before routine implementation.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bartłomiej Kamiński, Dominika Ochab, Janusz Kopczyński, Piotr Łacwik, Magdalena Bętkowska, Stanisław Flaga, Cezary Pałczyński
{"title":"Sinonasal Histopathological Changes After 12 Months of Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps.","authors":"Bartłomiej Kamiński, Dominika Ochab, Janusz Kopczyński, Piotr Łacwik, Magdalena Bętkowska, Stanisław Flaga, Cezary Pałczyński","doi":"10.3390/medsci14060686","DOIUrl":"10.3390/medsci14060686","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Dupilumab blocks the interleukin-4 receptor alpha (IL-4Rα) subunit, thereby inhibiting IL-4- and IL-13-mediated signaling, and is an effective treatment for severe chronic rhinosinusitis with nasal polyps (CRSwNP). This study assessed clinical response and histopathological changes reflecting eosinophilic inflammation and tissue remodeling after 12 months of dupilumab therapy. <b>Methods:</b> This prospective pilot real-world study included 27 patients with severe CRSwNP. Paired sinonasal mucosal biopsies were obtained before treatment and after 12 months. Histopathological assessment included tissue eosinophilia, basement membrane thickness, subepithelial edema, tissue neutrophilia, and Charcot-Leyden crystals (CLCs). Clinical outcomes included Nasal Polyp Score (NPS), Sino-Nasal Outcome Test-22 (SNOT-22), and the 12-item Sniffin' Sticks test. <b>Results:</b> Median NPS decreased from 6.0 [5.5-7.0] to 1.0 [1.0-1.0] (<i>p</i> < 0.001), SNOT-22 from 73.1 ± 15.7 to 14.9 ± 10.3 (<i>p</i> < 0.001), and olfactory scores increased from 2.85 ± 2.46 to 7.54 ± 3.19 (<i>p</i> < 0.001). Tissue eosinophils decreased from 122 [81-323] to 36 [19.5-76] cells/mm<sup>2</sup> (<i>p</i> < 0.001), basement membrane thickness from 6.0 [4.15-7.5] to 4.0 [3.15-5.0] µm (<i>p</i> = 0.0019), and subepithelial edema from grade 2 [2-3] to 1 [1-1] (<i>p</i> < 0.001). Tissue neutrophil counts did not change significantly, while CLC prevalence decreased from 7/27 (25.9%) to 0/27 (0%; <i>p</i> = 0.0156; Holm-adjusted <i>p</i> = 0.0469). <b>Conclusions:</b> Twelve months of dupilumab therapy was associated with marked clinical improvement and significant histopathological changes in the sinonasal mucosa. These findings indicate that clinical improvement during treatment was accompanied by changes in eosinophilic inflammation and selected structural features of tissue remodeling.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sorinel Lunca, Stefan Morarasu, Cristian Ene Roata, Gabriel Mihail Dimofte
{"title":"Association Between Low Anterior Resection Syndrome and Lower Urinary Tract Symptom Severity After Restorative Rectal Cancer Surgery.","authors":"Sorinel Lunca, Stefan Morarasu, Cristian Ene Roata, Gabriel Mihail Dimofte","doi":"10.3390/medsci14060682","DOIUrl":"10.3390/medsci14060682","url":null,"abstract":"<p><p><b>Background:</b> Low anterior resection syndrome (LARS) and lower urinary tract symptoms (LUTS) are common after restorative rectal cancer surgery, but whether their postoperative severity is associated after accounting for relevant clinical, anatomical, and treatment-related factors remains unclear. <b>Methods:</b> We conducted a retrospective, single-centre cohort study of patients treated for rectal cancer at the Regional Institute of Oncology, Iași, Romania, between 2013 and 2024. Patients were eligible if they underwent sphincter-preserving rectal resection, achieved restoration of bowel continuity, and completed the LARS score and International Prostate Symptom Score (IPSS) during the same postoperative telephone assessment. The primary analysis used proportional-odds ordinal logistic regression to evaluate the association between LARS and IPSS categories after adjustment for neoadjuvant radiotherapy, chemotherapy, extent of mesorectal excision, MRI-measured distance from the tumour to the anal verge, age, sex, body mass index, diabetes, and smoking. Multiple sensitivity and model-diagnostic analyses were performed to assess the robustness of the primary association. <b>Results:</b> Of 404 patients managed during the study period, 190 were included in the analytic cohort. Major LARS was present in 53 patients (27.9%), and moderate-to-severe LUTS in 84 (44.2%). LARS score and IPSS were modestly correlated (Pearson r = 0.225, <i>p</i> = 0.0018; Spearman ρ = 0.237, <i>p</i> = 0.0010). Moderate-to-severe LUTS occurred in 31 of 53 patients with major LARS (58.5%) and in 53 of 137 with no or minor LARS (38.7%; <i>p</i> = 0.021). In the primary adjusted model, each one-category increase in LARS severity was associated with greater IPSS severity (OR 1.75, 95% CI 1.25-2.46, <i>p</i> = 0.0012), and addition of LARS significantly improved model fit (likelihood-ratio χ<sup>2</sup> = 10.85, <i>p</i> = 0.0010). Major LARS was associated with approximately threefold higher odds of greater IPSS severity compared with no LARS (OR 3.05, 95% CI 1.54-6.04, <i>p</i> = 0.0014). Diabetes was also associated with greater IPSS severity after multivariable adjustment (OR 3.32, 95% CI 1.44-7.67, <i>p</i> = 0.0049). Results remained materially unchanged across sensitivity analyses. Item-level correlations were weak, and none remained significant after Bonferroni correction. <b>Conclusions:</b> Greater postoperative LARS severity was associated with greater contemporaneously measured LUTS severity after multivariable adjustment. This association was consistent across multiple correlated sensitivity analyses but does not establish temporal direction or a shared causal mechanism. Patients with major LARS may therefore warrant concurrent assessment for urinary symptoms during postoperative and survivorship follow-up.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Márió Gajdács, Irena Ilić, Dóra Szabó-Kurucz, Regina Molnár, Edit Paulik, Diána Elmer, Tímea Csákvári, Zsuzsanna Kívés
{"title":"Online Information-Seeking Behaviour for Major Cancers: A 10-Year Infodemiological Study to Inform Public Health and Health Promotion Priorities in Hungary.","authors":"Márió Gajdács, Irena Ilić, Dóra Szabó-Kurucz, Regina Molnár, Edit Paulik, Diána Elmer, Tímea Csákvári, Zsuzsanna Kívés","doi":"10.3390/medsci14060681","DOIUrl":"10.3390/medsci14060681","url":null,"abstract":"<p><p><b>Background/Objectives:</b> To analyse trends in online information-seeking behaviour for five major cancers in Hungary, compare them with global trends, and assess changes during the COVID-19 pandemic, cancer-related awareness campaigns, and major cancer-related events on search activity. <b>Methods:</b> A retrospective observational infodemiological study was conducted using Google Trends™ (GT) data for lung, colorectal, breast, prostate, and pancreatic cancers between 2013 and 2022. Search intensity was assessed using uncorrected relative search volume (RSV<sub>raw</sub>) as the primary measure, complemented by RSV<sub>sens</sub>, as an Internet penetration-adjusted sensitivity analysis. Descriptive statistics, parametric tests, time-series and seasonality analyses, Mann-Kendall tests, and joinpoint regression were performed using IBM SPSS Statistics 22.0, PAST 4.03, and Joinpoint 5.3.0 (α: 0.05; 95% confidence interval [CI]). Benjamini-Hochberg (BH) false discovery rate (FDR) correction was applied for multiple testing. <b>Results:</b> Among the cancer types relevant to our study, lung and breast cancer showed the highest reference-adjusted RSV (RSV<i><sub>ref</sub></i>: 61) in Hungary, followed by prostate (RSV<i><sub>ref</sub></i>: 59), colorectal (RSV<i><sub>ref</sub></i>: 52), and pancreatic cancer (RSV<i><sub>ref</sub></i>: 11); whereas globally, breast cancer ranked first (RSV<i><sub>ref</sub></i>: 49). RSV<sub>sens</sub> showed significant decreasing trends for all five cancer types (Mann-Kendall, all <i>p</i> < 0.05), with average annual percentage changes (AAPCs) of -5.39% for lung, -4.06% for breast, -3.56% for colorectal, -3.59% for prostate, and -5.23% for pancreatic cancer, respectively (all <i>p</i> < 0.05). Breast and prostate cancers exhibited significant (<i>p</i> < 0.001) and recurring seasonal peaks. During COVID-19 (vs. the pre-pandemic period), mean RSV values decreased by 10-30% across all cancers; only colorectal cancer-related campaigns were associated with a notable increase in search intensity (+66.9%, <i>p</i> = 0.013, <i>q</i> = 0.058), although this association did not remain significant after FDR correction.. Symptom-related searches predominated, whereas screening- and prevention-related queries were infrequent during the study period. <b>Conclusions:</b> GT may be a useful complementary tool for monitoring public interest and evaluating public health communication. The absence of consistent increases in search activity during most campaign periods, together with the predominance of symptom-related queries, suggests that current communication initiatives may have limited measurable visibility in GT search behaviour and highlights the need to strengthen communication on cancer prevention and early detection.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13706818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"<i>Candida auris</i> in the Middle East and North Africa: From Emerging Threat to Regional Healthcare Challenge.","authors":"Bahgat Fayed","doi":"10.3390/medsci14060679","DOIUrl":"10.3390/medsci14060679","url":null,"abstract":"<p><p><i>Candida auris</i> (also termed <i>Candidozyma auris</i>) (<i>C. auris</i>) is an emerging healthcare-associated yeast that has become a major concern because of its persistence in hospitals, frequent misidentification, multidrug resistance, and ability to cause outbreaks in critically ill patients. This review synthesizes the available evidence from the Gulf region, the Eastern Mediterranean region, and North Africa, with emphasis on reported case patterns, epidemiologic expansion, clade distribution, antifungal resistance, colonization-to-infection transition, mortality, and the impact of the COVID-19 period. The Gulf region carries the highest documented burden, with recurrent hospital outbreaks and large surveillance series reported from Saudi Arabia, Qatar, the United Arab Emirates, Kuwait, Oman, and Bahrain. Across the Eastern Mediterranean region, emergence has been more heterogeneous, but major amplification was observed during the COVID-19 era, particularly in Lebanon and Israel. North African data remain more limited, with Egypt and Algeria representing the main published settings; nevertheless, the available findings indicate recent emergence rather than true absence. Across the region, clade I predominates in most countries, suggesting a largely homogeneous South Asian lineage with efficient healthcare-associated transmission. Fluconazole resistance is nearly universal, amphotericin B susceptibility is variable, and echinocandin activity is usually preserved, although resistance to all major antifungal classes has been documented. Colonization often precedes invasive infection, especially among patients with ICU exposure, invasive devices, and prolonged hospitalization. Mortality remains substantial and is highest among patients with bloodstream infection or progression from colonization to invasive disease. The regional pattern is likely driven by a combination of healthcare infrastructure, surveillance intensity, diagnostic capacity, outbreak control, and pandemic-related strain on infection prevention systems.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diego Santos García, María Cerdán Sánchez, Rosa Yáñez Baña, Iria Cabo, Maria Icíar Cimas Hernando
{"title":"Differential Temporal Dynamics and Motor-Non-Motor Dissociation After Inhaled Levodopa in Parkinson's Disease: A Post Hoc Analysis of the INLEVO-LIFE PD Study.","authors":"Diego Santos García, María Cerdán Sánchez, Rosa Yáñez Baña, Iria Cabo, Maria Icíar Cimas Hernando","doi":"10.3390/medsci14060680","DOIUrl":"10.3390/medsci14060680","url":null,"abstract":"<p><strong>Background/objectives: </strong>OFF episodes in Parkinson's disease (PD) include motor and non-motor manifestations, but their resolution after on-demand therapy may not be synchronous. We examined within-patient temporal dynamics of motor and non-motor responses after inhaled levodopa.</p><p><strong>Methods: </strong>This post hoc analysis used data from the prospective, multicenter, open-label INLEVO-LIFE PD study. At week 12, UPDRS-III and 10 OFF-related non-motor symptoms (NMSs) were assessed in OFF and 30, 60, and 90 min after inhaled levodopa. The principal post hoc outcome was the proportion of maximum early (30-60 min) benefit retained at 90 min for motor versus non-motor outcomes. Individual trajectories were also examined descriptively.</p><p><strong>Results: </strong>Thirty-four participants had complete serial assessments. Mean UPDRS-III scores were 25.91, 11.21, 12.00, and 16.00 at OFF, 30, 60, and 90 min, respectively (<i>p</i> < 0.0001); corresponding NMSS-OFF/ON total scores were 6.65, 2.09, 1.91, and 2.71 (<i>p</i> < 0.0001). Among 28 participants with early improvement in both outcomes, median benefit retained at 90 min was 67.1% for motor symptoms versus 100% for NMSs (<i>p</i> = 0.0011). Motor and non-motor improvement magnitudes were not significantly correlated at any time point. Individual trajectories showed marked interindividual heterogeneity in the timing and persistence of motor and non-motor responses.</p><p><strong>Conclusions: </strong>Motor and non-motor OFF manifestations improved rapidly after inhaled levodopa but showed partially dissociated temporal trajectories, challenging the assumption that OFF resolution is necessarily synchronous across symptom dimensions. Greater relative persistence of non-motor benefit at 90 min is hypothesis-generating and requires confirmation using validated NMF instruments and controlled designs.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carlos M Ardila, Eliana Pineda-Vélez, Anny M Vivares-Builes
{"title":"AI-Guided Histopathological and Molecular Phenotyping of Salivary Glands in Sjögren's Disease: Subtyping, Mechanistic Insights, and Translational Implications-A Systematic Review and Structured Functional Synthesis.","authors":"Carlos M Ardila, Eliana Pineda-Vélez, Anny M Vivares-Builes","doi":"10.3390/medsci14060677","DOIUrl":"10.3390/medsci14060677","url":null,"abstract":"<p><strong>Background/objectives: </strong>Salivary-gland biopsy is central to Sjögren's disease (SjD) assessment, but conventional measures incompletely capture glandular heterogeneity. This systematic review evaluated artificial intelligence (AI)/machine learning (ML) applications to SjD salivary-gland histopathology and molecular profiling, including biological and translational validation.</p><p><strong>Methods: </strong>PubMed, Scopus, and Embase were searched. Eligible studies used salivary-gland tissue as the primary analytical substrate or provided substantive glandular validation of systemic AI/ML findings. Evidence was synthesized functionally because of methodological heterogeneity.</p><p><strong>Results: </strong>Twenty-five studies were included. AI/ML identified histopathological and molecular phenotypes spanning immune/interferon activation, tissue architecture and immune-cell organization, epithelial stress and metabolic/cell-death remodeling, and translational response. Only a limited subset progressed beyond computational or tissue-level confirmation to functional perturbation, pharmacological testing, in vivo validation, or human treatment-response assessment. Recurrent public-dataset reuse, small cohorts, heterogeneous pipelines, and limited independent validation constrained reproducibility.</p><p><strong>Conclusions: </strong>AI/ML supports multidimensional SjD glandular phenotyping and shows emerging translational potential, but demonstrated clinical or therapeutic utility remains unestablished. Prospective multicenter validation is required before AI-derived glandular phenotypes can inform routine patient stratification or therapeutic decision-making.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Transcriptomic Profiling Reveals METTL26 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma with Independent Validation in Oral Squamous Cell Carcinoma.","authors":"Rossella Rotondo, Alessandro Polizzi, Sabrina Donati Zeppa, Gaetano Isola, Roberto Campagna, Giovanni Tossetta","doi":"10.3390/medsci14060674","DOIUrl":"10.3390/medsci14060674","url":null,"abstract":"<p><p><b>Background:</b> Methyltransferase-like 26 (METTL26) is a poorly characterized member of the METTL family that has been included in previous pan-cancer analyses, but its disease-specific clinical and molecular relevance in head and neck squamous cell carcinoma (HNSCC) and oral squamous cell carcinoma (OSCC) remains poorly defined. The aim of this study was to investigate METTL26 expression and its potential clinical and biological relevance in HNSCC, with particular attention to OSCC. <b>Methods:</b> The TCGA-HNSC dataset was used as a discovery dataset. METTL26 expression and pathological stage were evaluated using GEPIA3, whereas survival associations were analyzed in R. Tumor microenvironment associations were investigated using TIMER3. Genes co-expressed with METTL26 were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, while protein interaction networks were explored using STRING. These discovery analyses were performed using the heterogeneous TCGA-HNSC cohort, whereas two independent OSCC cohorts (GSE37991 and GSE30784) were primarily used to validate differential expression. <b>Results:</b> METTL26 expression was significantly increased in TCGA-HNSC compared to normal tissues and was associated with pathological stage. High METTL26 expression showed a non-significant trend toward poorer OS and PFI and was not independently associated with either outcome after multivariable adjustment. A positive association with cancer-associated fibroblast (CAF) abundance was detected using TIDE, whereas an inverse association with endothelial cell abundance was observed across multiple algorithms. Functional analysis showed enrichment of mitochondrial gene expression, mitochondrial translation, ribosomal functions, oxidative phosphorylation, and reactive oxygen species-related pathways. METTL26 was also positively correlated with several genes involved in therapy response such as PTOV1, MIF, BAD, and EIF3C. Importantly, METTL26 upregulation was independently confirmed in both OSCC cohorts, GSE37991 and GSE30784. <b>Conclusions:</b> METTL26 upregulation was independently confirmed in two OSCC cohorts, supporting its potential relevance as an expression biomarker. In contrast, the observed associations with pathological stage, mitochondrial and redox-related programs, stromal composition, and therapy-response-related genes should be considered exploratory and hypothesis-generating and require independent and functional validation.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María Lourdes Del Río-Solá, Juan Martin-Hernandez, Alejandro Santos-Lozano
{"title":"Anabolic-Androgenic Steroid Use, All-Cause Mortality, and Major Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.","authors":"María Lourdes Del Río-Solá, Juan Martin-Hernandez, Alejandro Santos-Lozano","doi":"10.3390/medsci14060678","DOIUrl":"10.3390/medsci14060678","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Non-medical anabolic-androgenic steroid (AAS) use has been associated with adverse cardiac remodelling, but the magnitude of excess all-cause mortality and the cardiac phenotype of former users remain incompletely defined. <b>Methods:</b> We systematically reviewed studies reporting mortality, major cardiovascular outcomes, or cardiac function after cessation in AAS-exposed individuals. All-cause mortality was pooled from comparative cohorts with individually ascertained exposure using random-effects models; global longitudinal strain (GLS) and left ventricular ejection fraction in former users were pooled as mean differences. Risk of bias was assessed with ROBINS-E and certainty with GRADE. <b>Results:</b> Fifteen primary reports were included. Across three cohorts, AAS exposure was associated with higher all-cause mortality (risk ratio 2.57, 95% CI 1.98-3.33; I<sup>2</sup> = 0%; 95% prediction interval 0.47-13.87), with consistent sensitivity analyses. In a single large matched cohort, adjusted hazard ratios for cardiovascular outcomes ranged from 2.26 to 8.90, highest for cardiomyopathy. Former users had worse GLS than AAS-naïve controls (3 studies; mean difference +0.90 percentage points, 95% CI +0.13 to +1.66), whereas the pooled ejection-fraction estimate was exploratory and highly heterogeneous. <b>Conclusions:</b> AAS exposure was associated with higher all-cause mortality in three observational cohorts, but residual confounding, differing follow-up, and the small evidence base preclude causal inference. Cardiovascular associations from a single cohort require independent replication, and evidence on residual myocardial dysfunction in former users is of very low certainty.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anastasiya A Luenkova, Galina I Kuzovleva, Marina A Korshunova, Darya A Perfilyeva, Ramil M Akhmetov, Elena Yu Danilova, Dmitrii A Morozov, Mikhail K Beklemishev, Olga L Morozova
{"title":"Fluorescence Profiling of Urine in Non-Invasive Diagnostics of Obstructive and Reflux Uropathies in Children.","authors":"Anastasiya A Luenkova, Galina I Kuzovleva, Marina A Korshunova, Darya A Perfilyeva, Ramil M Akhmetov, Elena Yu Danilova, Dmitrii A Morozov, Mikhail K Beklemishev, Olga L Morozova","doi":"10.3390/medsci14060675","DOIUrl":"10.3390/medsci14060675","url":null,"abstract":"<p><strong>Background: </strong>Rapid screening methods reflecting the metabolic profile of urine are promising for assessing the risk of decreased renal function in children with obstructive uropathies. The aim of this pilot study was to evaluate the applicability of a reaction-based fingerprinting strategy for this purpose, which has previously demonstrated its effectiveness in recognizing samples with similar composition.</p><p><strong>Methods: </strong>The study included 28 children with hydronephrosis (HN, 5 patients) and vesicoureteral reflux (VUR, 15 patients), as well as healthy children without urinary pathology who comprised the control group (8 patients). Using the kinetic variant of optical fingerprinting, six indicator reactions of different natures involving dyes were investigated, with absorbance and fluorescence of the reaction products monitored photographically throughout the reaction.</p><p><strong>Results: </strong>Supervised chemometric analysis demonstrated that standard clinical and laboratory indicators enabled discrimination of urine samples from children with HN and VUR from the control group; however, the recognition accuracy was only satisfactory, ranging from 79% to 86%. The introduction of urine samples into the indicator reactions enabled discrimination of both diagnoses (VUR and HN) from the control group and from each other, with recognition accuracy reaching 100%. Furthermore, no correlation was observed between the results obtained using kinetic-based methods and standard clinical and laboratory indicators, which may reflect different levels of the pathological process, namely functional and molecular.</p><p><strong>Conclusions: </strong>The reaction-based optical fingerprinting strategy can be considered a promising approach for in-depth non-invasive diagnostics in pediatric urology. The reported diagnostic performance is limited to the analyzed cohort and should not be extrapolated to general clinical use without independent validation in a larger, age-matched population. If validated, kinetic optical fingerprinting could serve as an adjunct to conventional imaging and clinical assessment to inform risk stratification and guide further investigations, rather than functioning as a stand-alone decision-maker.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"14 6","pages":""},"PeriodicalIF":4.4,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13707345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}